Persistence of both cords nine months post double cord blood transplantation for juvenile myelomonocytic leukaemia

Hematology/ Oncology and Stem Cell Therapy

Volumn 6, Issue 2, 2013, Pages 79-80

  Yadav, Satya Prakash ^a   Dhingra, Nivedita ^a   Saxena, Renu ^a   Sachdeva, Anupam ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FOSCARNET; GANCICLOVIR; IMATINIB; MELPHALAN; PREDNISOLONE; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ANTIVIRAL RESISTANCE; CASE REPORT; CHILD; CHRONIC DISEASE; CLINICAL FEATURE; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; DOUBLE CORD BLOOD TRANSPLANTATION; DRUG DOSE REDUCTION; DRUG EFFECT; ENTEROPATHY; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; LETTER; MALE; MYELOABLATIVE CONDITIONING; PRESCHOOL CHILD; PROPHYLAXIS; RASH; SKIN DISEASE; SYSTEMIC THERAPY; VIRUS REACTIVATION;

EID: 84884693661     PISSN: 16583876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hemonc.2013.04.002     Document Type: Article

References (5)

1. Milano F, Heimfeld S, Gooley T, Jinneman J, Nicoud I, Delaney C. Correlation of infused CD3+CD8+ cells with single-donor dominance after double-unit cord blood transplantation. Biol Blood Marrow Transplant 2013;19(1):156-60.
2. Kang HJ, Yoo KH, Lee JW, et al.. Double umbilical cord blood transplantation for children and adolescents. Ann Hematol 2010;89(10):1035-44.
3. Scaradavou A, Smith KM, Hawke R, et al.. Cord blood units with low CD34 cell viability have a low probability of engraftment after double unit transplantation. Biol Blood Marrow Transplant 2010;16(4):500-8.
4. Avery S, Shi W, Lubin M, et al.. Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts. Blood 2011;117(12):3277-85.
5. Verneris MR, Brunstein CG, Barker J, et al.. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 2009;114(19):4293-9.